Jiang Liu

4.9k total citations · 4 hit papers
33 papers, 3.4k citations indexed

About

Jiang Liu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jiang Liu has authored 33 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Jiang Liu's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jiang Liu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jiang Liu collaborates with scholars based in China, United States and Hong Kong. Jiang Liu's co-authors include Jin Xu, Xianjun Yu, Si Shi, Chen Liang, Jie Hua, Qingcai Meng, Wei Wang, Bo Zhang, Xiaoqi Mao and Bo Zhang and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Jiang Liu

33 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

2021 1.4k citations Xiaoqi Mao, Jin Xu et al. Molecular Cancer profile →
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

2020 930 citations Rong Tang, Jin Xu et al. Journal of Hematology & Oncology profile →
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives

2022 151 citations Qingcai Meng, Jin Xu et al. Cancer Communications profile →
Functional significance of cholesterol metabolism in cancer: from threat to treatment

2023 111 citations Mingming Xiao, Jin Xu et al. Experimental & Molecular Medicine profile →

Peers

Countries citing papers authored by Jiang Liu

Since Specialization

Citations

This map shows the geographic impact of Jiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Liu more than expected).

Fields of papers citing papers by Jiang Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Liu. The network helps show where Jiang Liu may publish in the future.

Co-authorship network of co-authors of Jiang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Liu. A scholar is included among the top collaborators of Jiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Liu. Jiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human Umbilical Cord–Mesenchymal Stem Cells Combined With Low Dosage Nintedanib Rather Than Using Alone Mitigates Pulmonary Fibrosis in Mice 2025 ·Stem Cells International ·Huijun Qiu, Rong Zhang, (unknown), (unknown), Jiang Liu, (unknown), Zhou Ou, (unknown), Ke Yang, (unknown), (unknown), Enmei Liu, Lin Zou, Zhou Fu, (unknown)	1
2	Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung Cancer 2025 ·OncoTargets and Therapy ·Jianhua Liu, (unknown), Jiang Liu, (unknown), (unknown)	1
3	Protac synthesized on the basis of azaflavonoid derivatives possesses favorable anti-hepatocellular carcinoma activity 2025 ·Bioorganic Chemistry ·(unknown), Yanping Li, Zhaoyang Wang, Xueping Xu, Yi Xiang, Fei Teng, (unknown), Jiang Liu, Zhen Liu, (unknown), Yuou Teng	1
4	Dense stroma activates the TGF-β1/FBW7 axis to induce metabolic subtype switching in pancreatic cancer 2025 ·International Journal of Surgery ·Zeyin Rong, Jianhui Yang, Jiang Liu, Qingcai Meng, Jie Hua, Zhen Tan, Bo Zhang, Yuan Liu, Qiong Du, Wei Wang, Xianjun Yu, Jin Xu, Chen Liang	4
5	Ferroptotic Neutrophils Induce Immunosuppression and Chemoresistance in Breast Cancer 2024 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jiang Liu, (unknown), Di Huang, (unknown)	14
6	Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer 2023 ·International Journal of Molecular Sciences ·Chen Liang, Zeyin Rong, (unknown), Qingcai Meng, Jie Hua, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, Si Shi, Jin Xu	3
7	Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges 2023 ·International Journal of Molecular Sciences ·Zhilong Ma, Jie Hua, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, Jin Xu	9
8	Functional significance of cholesterol metabolism in cancer: from threat to treatment breakdown → 2023 ·Experimental & Molecular Medicine ·Mingming Xiao, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, (unknown), Hang Xu, Yingjun Zhao, Xianjun Yu, Si Shi	111
9	Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives breakdown → 2022 ·Cancer Communications ·(unknown), Qingcai Meng, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Yingjun Zhao, Xianjun Yu, Si Shi	151
10	Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma 2022 ·Translational Oncology ·Xiaomeng Liu, Jiang Liu, Jin Xu, Bo Zhang, Miaoyan Wei, (unknown), Hang Xu, Xianjun Yu, Wei Wang, Si Shi	5
11	From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors 2021 ·Frontiers in Immunology ·Miaoyan Wei, Jin Xu, Jie Hua, Qingcai Meng, Chen Liang, Jiang Liu, Bo Zhang, Wei Wang, Xianjun Yu, Si Shi	7
12	Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives breakdown → 2021 ·Molecular Cancer ·Xiaoqi Mao, Jin Xu, Wei Wang, Chen Liang, Jie Hua, Jiang Liu, Bo Zhang, Qingcai Meng, Xianjun Yu, Si Shi	1429
13	Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma 2021 ·Frontiers in Immunology ·Rong Tang, Xiaomeng Liu, Chen Liang, Jie Hua, Jin Xu, Wei Wang, Qingcai Meng, Jiang Liu, Bo Zhang, Xianjun Yu, Si Shi	40
14	Ferroptosis, necroptosis, and pyroptosis in anticancer immunity breakdown → 2020 ·Journal of Hematology & Oncology ·Rong Tang, Jin Xu, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Qingcai Meng, Xianjun Yu, Si Shi	930
15	The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications 2019 ·Molecular Cancer ·Xiaomeng Liu, Jin Xu, Bo Zhang, Jiang Liu, Chen Liang, Qingcai Meng, Jie Hua, (unknown), Si Shi	64
16	Role of angiogenesis in pancreatic cancer biology and therapy 2018 ·Biomedicine & Pharmacotherapy ·Zheng Zhang, Shunrong Ji, Bo Zhang, Jiang Liu, Yi Qin, Jin Xu, Xianjun Yu	50
17	Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma 2017 ·Molecular Cancer Research ·Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu, Quanxing Ni, Jin Xu, Xianjun Yu	46
18	FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer 2016 ·Clinical Cancer Research ·Shunrong Ji, Yi Qin, Chen Liang, Run Huang, Si Shi, Jiang Liu, Kaizhou Jin, Dingkong Liang, Wenyan Xu, Bo Zhang, Liang Liu, Chen Liu, Jin Xu, Quanxing Ni, Paul J. Chiao, Min Li, Xianjun Yu	76
19	Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma 2016 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Chen Liang, Yi Qin, Bo Zhang, Shunrong Ji, Si Shi, Wenyan Xu, Jiang Liu, Jinfeng Xiang, Dingkong Liang, Qiangsheng Hu, Quanxing Ni, Jin Xu, Xianjun Yu	33
20	ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer 2015 ·Cell Research ·Shunrong Ji, Yi Qin, Si Shi, Xiangyuan Liu, Hongli Hu, Hu Zhou, Jing Gao, Bo Zhang, Wenyan Xu, Jiang Liu, Dingkong Liang, Liang Liu, Chen Liu, Jiang Long, Haijun Zhou, Paul J. Chiao, Jin Xu, Quanxing Ni, Daming Gao, Xianjun Yu	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact